Ohr Pharmaceutical Inc (37) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Underwriting Agreement, dated as of April 22, 2021, by and among NeuBase Therapeutics, Inc. and RBC Capital Markets, LLC, Oppenheimer & Co. Inc. and Chardan Capital Markets LLC,... (Filed With SEC on April 22, 2021)
Registration Rights Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signature pages thereto (Filed With SEC on July 12, 2019)
Common Stock Purchase Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signatures pages thereto (Filed With SEC on July 12, 2019)
Form of NeuBase Therapeutics, Inc. Warrant Certificate (Filed With SEC on March 8, 2019)
Form of NeuBase Therapeutics, Inc. Note Purchase Agreement (Filed With SEC on March 8, 2019)
Underwriting Agreement, dated as of April 28, 2020, by and between NeuBase Therapeutics, Inc. and Oppenheimer & Co. Inc. and BTIG, LLC, as representatives of the underwriters... (Filed With SEC on April 29, 2020)
Form of NeuBase Therapeutics, Inc. Convertible Promissory Note (Filed With SEC on March 8, 2019)
Restricted Stock Purchase Agreement, made as of September 6, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)
Amendment to Restricted Stock Purchase Agreement, made as of December 26, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan (Filed With SEC on March 8, 2019)